AGP Executive Report
Last update: 7 hours agoMedicine Manufacturing: Icelandic biotech Alvotech won US FDA approval for a new SIMLANDI production process at its Reykjavík facility, more than doubling output per batch and freeing capacity for other medicines. Adolescent Obesity: A European procedure has backed extending QSIVA, a weight-management medicine, to patients aged 12 and over; Iceland is among 17 countries where national approval decisions are now expected. Retirement and Well-being: Iceland ranked third in the 2026 global pension index, scoring 84.0 and earning the top grade for its retirement system.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.